DCF — MYMICHIGAN MEDICAL CENTER SAULT
Enterprise Value: $-60.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-60.4M
Enterprise Value
$-19.9M
PV of Cash Flows
$-40.5M
PV of Terminal Value
$-65.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $61.4M | $-3.3M | -5.0% | $-5.9M | $-5.4M |
| Year 2 | $63.2M | $-2.8M | -4.0% | $-5.5M | $-4.5M |
| Year 3 | $65.1M | $-2.2M | -3.0% | $-5.0M | $-3.7M |
| Year 4 | $67.1M | $-2.0M | -3.0% | $-4.8M | $-3.3M |
| Year 5 | $69.1M | $-1.8M | -3.0% | $-4.8M | $-3.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-60.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$59.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.059199933817583004
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5